DE60203937D1 - Herstellung von trans-kondensierte 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivaten - Google Patents
Herstellung von trans-kondensierte 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatenInfo
- Publication number
- DE60203937D1 DE60203937D1 DE60203937T DE60203937T DE60203937D1 DE 60203937 D1 DE60203937 D1 DE 60203937D1 DE 60203937 T DE60203937 T DE 60203937T DE 60203937 T DE60203937 T DE 60203937T DE 60203937 D1 DE60203937 D1 DE 60203937D1
- Authority
- DE
- Germany
- Prior art keywords
- trans
- preparation
- cyclohepta
- dibenzo
- tetrahydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01204961 | 2001-12-07 | ||
EP01204961 | 2001-12-07 | ||
PCT/EP2002/013560 WO2003048146A1 (en) | 2001-12-07 | 2002-12-02 | PREPARATION OF TRANS-FUSED 3,3a,8,12b-TETRAHYDRO-2H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-b]FURAN DERIVATIVES |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60203937D1 true DE60203937D1 (de) | 2005-06-02 |
DE60203937T2 DE60203937T2 (de) | 2006-05-11 |
Family
ID=8181460
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60203937T Expired - Lifetime DE60203937T2 (de) | 2001-12-07 | 2002-12-02 | Herstellung von trans-kondensierte 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivaten |
Country Status (21)
Country | Link |
---|---|
US (2) | US6998494B2 (de) |
EP (1) | EP1456193B1 (de) |
JP (1) | JP4516752B2 (de) |
KR (1) | KR20050044329A (de) |
CN (1) | CN1293066C (de) |
AT (1) | ATE294168T1 (de) |
AU (1) | AU2002342926B2 (de) |
BR (1) | BR0214068A (de) |
CA (1) | CA2468038C (de) |
DE (1) | DE60203937T2 (de) |
ES (1) | ES2242076T3 (de) |
HK (1) | HK1076461A1 (de) |
HR (1) | HRP20040490A2 (de) |
HU (1) | HUP0402152A3 (de) |
IL (1) | IL162349A0 (de) |
MX (1) | MXPA04005400A (de) |
NO (1) | NO20042884L (de) |
NZ (1) | NZ532806A (de) |
PL (1) | PL369585A1 (de) |
WO (1) | WO2003048146A1 (de) |
ZA (1) | ZA200404394B (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60203937T2 (de) * | 2001-12-07 | 2006-05-11 | Janssen Pharmaceutica N.V. | Herstellung von trans-kondensierte 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivaten |
WO2005013969A1 (en) * | 2003-07-15 | 2005-02-17 | Janssen Pharmaceutica N.V. | Antipsychotic agent with socializing properties |
TW200612899A (en) * | 2004-06-14 | 2006-05-01 | Janssen Pharmaceutica Nv | Novel tetracyclic tetrahydrofuran derivatives |
CA2577305C (en) * | 2004-08-31 | 2013-12-17 | Janssen Pharmaceutica N.V. | Process for the production of [2-(4-fluoro-benzyl)-phenyl]-acetic acid |
RU2401257C2 (ru) | 2004-12-07 | 2010-10-10 | Янссен Фармацевтика Н.В. | Новые замещенные тетрациклические производные тетрагидрофурана, пирролидина и тетрагидротиофена |
MX2007009092A (es) | 2005-01-27 | 2007-09-12 | Janssen Pharmaceutica Nv | Derivados de tetrahidrofurano tetraciclicos heterociclicos como inhibidores de 5ht2 en el tratamiento de trastornos del sistema nervioso central. |
AU2006259020C1 (en) | 2005-06-17 | 2012-01-19 | Janssen Pharmaceutica N.V. | Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69720709T2 (de) | 1996-04-12 | 2004-03-11 | Janssen Pharmaceutica N.V. | Substituierte tetracyclische tetrahydrofuranderivate |
UA52778C2 (uk) * | 1997-10-10 | 2003-01-15 | Янссен Фармацевтика Н.В. | Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі |
UA79248C2 (en) * | 2001-11-09 | 2007-06-11 | Janssen Pharmaceutica Nv | Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives |
PL370440A1 (en) * | 2001-12-07 | 2005-05-30 | Janssen Pharmaceutica N.V. | Preparation of cis-fused 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives |
DE60203937T2 (de) * | 2001-12-07 | 2006-05-11 | Janssen Pharmaceutica N.V. | Herstellung von trans-kondensierte 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivaten |
-
2002
- 2002-12-02 DE DE60203937T patent/DE60203937T2/de not_active Expired - Lifetime
- 2002-12-02 BR BR0214068-3A patent/BR0214068A/pt not_active Withdrawn
- 2002-12-02 HU HU0402152A patent/HUP0402152A3/hu unknown
- 2002-12-02 AU AU2002342926A patent/AU2002342926B2/en not_active Ceased
- 2002-12-02 CN CNB028244885A patent/CN1293066C/zh not_active Expired - Fee Related
- 2002-12-02 PL PL02369585A patent/PL369585A1/xx not_active Application Discontinuation
- 2002-12-02 KR KR1020047005553A patent/KR20050044329A/ko not_active Application Discontinuation
- 2002-12-02 MX MXPA04005400A patent/MXPA04005400A/es active IP Right Grant
- 2002-12-02 EP EP02779576A patent/EP1456193B1/de not_active Expired - Lifetime
- 2002-12-02 US US10/496,279 patent/US6998494B2/en not_active Expired - Fee Related
- 2002-12-02 ES ES02779576T patent/ES2242076T3/es not_active Expired - Lifetime
- 2002-12-02 JP JP2003549337A patent/JP4516752B2/ja not_active Expired - Fee Related
- 2002-12-02 AT AT02779576T patent/ATE294168T1/de not_active IP Right Cessation
- 2002-12-02 WO PCT/EP2002/013560 patent/WO2003048146A1/en active IP Right Grant
- 2002-12-02 IL IL16234902A patent/IL162349A0/xx not_active IP Right Cessation
- 2002-12-02 NZ NZ532806A patent/NZ532806A/en unknown
- 2002-12-02 CA CA2468038A patent/CA2468038C/en not_active Expired - Fee Related
-
2004
- 2004-05-31 HR HR20040490A patent/HRP20040490A2/hr not_active Application Discontinuation
- 2004-06-03 ZA ZA200404394A patent/ZA200404394B/en unknown
- 2004-07-07 NO NO20042884A patent/NO20042884L/no not_active Application Discontinuation
-
2005
- 2005-05-31 US US11/141,612 patent/US20050228043A1/en not_active Abandoned
- 2005-09-23 HK HK05108415A patent/HK1076461A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1456193A1 (de) | 2004-09-15 |
US20050014820A1 (en) | 2005-01-20 |
US6998494B2 (en) | 2006-02-14 |
WO2003048146A1 (en) | 2003-06-12 |
AU2002342926A1 (en) | 2003-06-17 |
KR20050044329A (ko) | 2005-05-12 |
NZ532806A (en) | 2006-01-27 |
CA2468038A1 (en) | 2003-06-12 |
CN1293066C (zh) | 2007-01-03 |
EP1456193B1 (de) | 2005-04-27 |
JP2005511691A (ja) | 2005-04-28 |
CN1602306A (zh) | 2005-03-30 |
ATE294168T1 (de) | 2005-05-15 |
ES2242076T3 (es) | 2005-11-01 |
NO20042884L (no) | 2004-07-07 |
HUP0402152A2 (hu) | 2005-02-28 |
IL162349A0 (en) | 2005-11-20 |
BR0214068A (pt) | 2004-10-13 |
ZA200404394B (en) | 2005-09-05 |
PL369585A1 (en) | 2005-05-02 |
JP4516752B2 (ja) | 2010-08-04 |
US20050228043A1 (en) | 2005-10-13 |
AU2002342926B2 (en) | 2009-02-26 |
MXPA04005400A (es) | 2004-10-11 |
HK1076461A1 (en) | 2006-01-20 |
DE60203937T2 (de) | 2006-05-11 |
HRP20040490A2 (en) | 2004-10-31 |
CA2468038C (en) | 2011-04-26 |
HUP0402152A3 (en) | 2007-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1076461A1 (en) | Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzoÄ3,4;6,7ÜcycloheptaÄ1,2-bÜfuran derivatives | |
HUP9701048A2 (hu) | Új eljárás sildenafil előállítására és a felhasznált új köztitermékek | |
NZ522568A (en) | Substituted bicyclic derivatives for the treatment of abnormal cell growth | |
SE0102616D0 (sv) | Novel compounds | |
EP1256588A4 (de) | Neue pyrazin-derivate oder salze davon, pharmazeutische zusammensetzungen, die die derivate oder deren salze enthalten und intermediate zu beider herstellung | |
TNSN07485A1 (fr) | Derives de n-(arylalkyl)-1h-pyrrolopyridine -2- carboxamides, leur preparation et leur application en therapeutique | |
MXPA03011954A (es) | Nuevos derivados de acido sulfonico. | |
EP1193256A8 (de) | Pharmazeutisch aktive Benzolsulfonamidderivate als JNK-Proteininhibitoren | |
NO20023405D0 (no) | Fremgangsmåte for fremstilling av 5-Cyanoftalid | |
MXPA04005399A (es) | Preparacion de derivados cis-fusionados de 3, 3a, 8, 12b-tetrahidro-2h-dibenzo [3,4:6,7]ciclohepta[1,2-b]furano. | |
ATE239722T1 (de) | Benzofurylpiperazine als serotonin-agonisten | |
WO2001056992A3 (en) | Dibenzo (b,f) azepine intermediates | |
HUP0301942A2 (hu) | Eljárás citalopram elżállítására | |
EA200001101A1 (ru) | НОВЫЕ ДИГИДРОФУРО[3,4-b]ХИНОЛИН-1-ОНЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ | |
MXPA04003278A (es) | Derivados de 5-metoxi-8-aril-?1,2,4?triazolo?1,5-a?piridina como antagonistas del receptor de adenosina. | |
MXPA05008400A (es) | Derivados de oxazolidinona n-sustituidos por un anillo triciclico, para su uso como agentes antibacterianos. | |
AU6594900A (en) | Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof andagents | |
BG106846A (en) | Novel heteroaryl derivatives, their preparation and use | |
EE200300058A (et) | Imidaso[1,2-c] [2,3] bensodiasepiinide valmistamismeetod ja vaheühendid nende valmistamisel | |
EP1148059A4 (de) | Thiazolpyrimidin-verbindungen, verfahren zu ihrer herstellung und ihre anwendung | |
FI104078B (fi) | Menetelmä terapeuttisesti käyttökelpoisten (3-(1-piperatsinyyli)tieno£2,3-b|- ja -£2,3-c|pyridiinijohdannaisten valmistamiseksi | |
ES2082202T3 (es) | Derivados de biciclo(3.3.0)octano, procedimiento para su preparacion y su utilizacion farmaceutica. | |
DK1490391T3 (da) | 11beta-langkædet substituerede 19-nor-17alfa-pregna-1,3,5(10)-trien-17beta-oler med en 21,2alfa-lactonring |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |